Q: What is Cinryze used for?

Cinryze is used to treat hereditary angioedema .

Q: How does Cinryze work?

Restoring Protein Levels Hereditary angioedema (HAE) is a genetic condition where the body does not make enough of a protein called C1 esterase inhibitor, or the protein it makes does not work properly. This protein is essential for controlling inflammation and fluid balance in the body. Preventing Swelling Without enough functional C1 esterase inhibitor, the body overproduces a peptide called bradykinin. High levels of bradykinin cause blood vessels to leak fluid into the surrounding tissues, resulting in the sudden and severe swelling episodes seen in HAE. These attacks can affect the face, limbs, abdomen, and airway. Cinryze works as a replacement therapy. It provides the body with the human C1 esterase inhibitor protein it is missing. By increasing the levels of this protein in the blood, Cinryze helps to: Regulate the inflammatory response: It helps the immune system maintain proper control over inflammation. Block bradykinin production: It stops the chemical reactions that lead to the overproduction of bradykinin. Maintain fluid balance: It helps keep fluid inside the blood vessels, which prevents it from leaking into tissues and causing edema. Because Cinryze helps maintain a more stable level of this protein, it is used as a routine preventive treatment to reduce the number and severity of HAE attacks.

Q: What are the active ingredients in Cinryze?

The active ingredient in Cinryze is C1 esterase inhibitor .

Q: What are the side effects of Cinryze?

Common side effects of Cinryze may include: headache nausea rash and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Cinryze?

Cinryze belongs to the C1 esterase inhibitor drug class.

Q: What is the dosage of Cinryze and how do I take it?

How Cinryze is Given Cinryze is administered as an injection into a vein (intravenous). It is used as a routine preventive treatment rather than a rescue medication for active attacks. A healthcare professional may teach you or a caregiver how to prepare and administer the injection at home so you can manage your treatment outside of a clinical setting. Preparation Cinryze comes as a powder that must be mixed with sterile water before use. When mixing the medication, swirl the vial gently. Do not shake it, as shaking can damage the proteins and make the medicine less effective. The mixed solution should be clear and colorless. If the liquid is cloudy, discolored, or contains visible particles, do not use it. Once mixed, the medication should be used promptly according to your provider's instructions. Dosing Schedule This medication is typically administered every three or four days on a regular schedule. It is important to use the medication exactly as directed by your healthcare provider to maintain consistent levels in the blood and provide continuous protection against swelling. Missed Dose If you miss a scheduled dose, contact your doctor or pharmacist immediately for guidance on when to take your next dose. Do not administer a double dose to make up for the one you missed.

Q: Is Cinryze safe during pregnancy and breastfeeding?

Pregnancy There is limited information regarding the safety of Cinryze during pregnancy. Animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans to determine if the medication causes fetal harm or affects reproductive capacity. Because the risks are not fully understood, Cinryze should only be used during pregnancy if a healthcare provider determines it is clearly needed. Breastfeeding It is unknown whether Cinryze passes into human breast milk. Because many medications can be excreted in milk, caution is recommended for individuals who are breastfeeding. It is important to discuss the potential risks and benefits with a doctor before using this medication while nursing. Consulting Your Doctor If you are pregnant, planning to become pregnant, or breastfeeding, you should inform your healthcare provider before starting treatment. They can help evaluate the necessity of the medication based on your specific medical situation.

Q: What forms and strengths does Cinryze come in?

Dosage Forms Cinryze is available as a lyophilized (freeze-dried) powder for reconstitution. It is supplied in a single-use glass vial. Each vial is typically packaged with a separate vial of sterile water for injection, which is used to dissolve the powder before administration. Strengths This medication is available in the following strength: 500 Units of C1 esterase inhibitor (human) per vial Route of Administration Once the powder is mixed with the provided sterile water, the resulting solution is administered as an intravenous injection. It is not intended for other routes of administration, such as subcutaneous injection.

Q: What is the FDA approval status of Cinryze?

FDA Approval History The U.S. Food and Drug Administration (FDA) approved Cinryze in October 2008. It was the first C1 esterase inhibitor approved in the United States for the routine prevention of hereditary angioedema (HAE) attacks. Approved Indications Cinryze is indicated for routine prophylaxis against angioedema attacks in the following populations: Adults Adolescents Pediatric patients ages 6 years and older The medication is intended for regular, scheduled use to prevent symptoms from occurring. It is not approved for the immediate treatment of an acute HAE attack. Regulatory and Safety Oversight As a biological product derived from human plasma, Cinryze is subject to strict regulatory standards regarding its manufacturing process. Because it is made from human blood, there is a theoretical risk of transmitting infectious agents, such as viruses or the agent that causes Creutzfeldt-Jakob disease. To mitigate these risks, the FDA requires rigorous donor screening and specific viral inactivation and removal steps during the manufacturing process. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) programs required by the FDA for Cinryze.

Question 1

What is Cinryze?

Accepted Answer

Cinryze is a purified form of C1 esterase inhibitor, which is a protein that occurs naturally in human blood. This protein is responsible for regulating several complex systems in the body, including those that control inflammation and blood vessel permeability. It works by blocking certain enzymes that would otherwise cause fluid to leak into body tissues.

When the body lacks a sufficient amount of this protein, it can lead to uncontrolled swelling. This medication supplements the body's natural levels to help stabilize these inflammatory pathways. Its general purpose is to provide long-term protection against the recurrence of severe swelling episodes.

Question 2

What is Cinryze used for?

Accepted Answer

Cinryze is used to treat hereditary angioedema.

Question 3

How does Cinryze work?

Accepted Answer

Restoring Protein Levels

Hereditary angioedema (HAE) is a genetic condition where the body does not make enough of a protein called C1 esterase inhibitor, or the protein it makes does not work properly. This protein is essential for controlling inflammation and fluid balance in the body.

Preventing Swelling

Without enough functional C1 esterase inhibitor, the body overproduces a peptide called bradykinin. High levels of bradykinin cause blood vessels to leak fluid into the surrounding tissues, resulting in the sudden and severe swelling episodes seen in HAE. These attacks can affect the face, limbs, abdomen, and airway.

Cinryze works as a replacement therapy. It provides the body with the human C1 esterase inhibitor protein it is missing. By increasing the levels of this protein in the blood, Cinryze helps to:

Regulate the inflammatory response: It helps the immune system maintain proper control over inflammation.
Block bradykinin production: It stops the chemical reactions that lead to the overproduction of bradykinin.
Maintain fluid balance: It helps keep fluid inside the blood vessels, which prevents it from leaking into tissues and causing edema.

Because Cinryze helps maintain a more stable level of this protein, it is used as a routine preventive treatment to reduce the number and severity of HAE attacks.

Question 4

What are the active ingredients in Cinryze?

Accepted Answer

The active ingredient in Cinryze is C1 esterase inhibitor.

Question 5

What are the side effects of Cinryze?

Accepted Answer

Common side effects of Cinryze may include:

headache
nausea
rash
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Cinryze?

Accepted Answer

Cinryze belongs to the C1 esterase inhibitor drug class.

Question 7

What is the dosage of Cinryze and how do I take it?

Accepted Answer

How Cinryze is Given

Cinryze is administered as an injection into a vein (intravenous). It is used as a routine preventive treatment rather than a rescue medication for active attacks. A healthcare professional may teach you or a caregiver how to prepare and administer the injection at home so you can manage your treatment outside of a clinical setting.

Preparation

Cinryze comes as a powder that must be mixed with sterile water before use.
When mixing the medication, swirl the vial gently. Do not shake it, as shaking can damage the proteins and make the medicine less effective.
The mixed solution should be clear and colorless. If the liquid is cloudy, discolored, or contains visible particles, do not use it.
Once mixed, the medication should be used promptly according to your provider's instructions.

Dosing Schedule

This medication is typically administered every three or four days on a regular schedule. It is important to use the medication exactly as directed by your healthcare provider to maintain consistent levels in the blood and provide continuous protection against swelling.

Missed Dose

If you miss a scheduled dose, contact your doctor or pharmacist immediately for guidance on when to take your next dose. Do not administer a double dose to make up for the one you missed.

Question 8

Is Cinryze safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of Cinryze during pregnancy. Animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans to determine if the medication causes fetal harm or affects reproductive capacity. Because the risks are not fully understood, Cinryze should only be used during pregnancy if a healthcare provider determines it is clearly needed.

Breastfeeding

It is unknown whether Cinryze passes into human breast milk. Because many medications can be excreted in milk, caution is recommended for individuals who are breastfeeding. It is important to discuss the potential risks and benefits with a doctor before using this medication while nursing.

Consulting Your Doctor

If you are pregnant, planning to become pregnant, or breastfeeding, you should inform your healthcare provider before starting treatment. They can help evaluate the necessity of the medication based on your specific medical situation.

Question 9

What forms and strengths does Cinryze come in?

Accepted Answer

Dosage Forms

Cinryze is available as a lyophilized (freeze-dried) powder for reconstitution. It is supplied in a single-use glass vial. Each vial is typically packaged with a separate vial of sterile water for injection, which is used to dissolve the powder before administration.

Strengths

This medication is available in the following strength:

500 Units of C1 esterase inhibitor (human) per vial

Route of Administration

Once the powder is mixed with the provided sterile water, the resulting solution is administered as an intravenous injection. It is not intended for other routes of administration, such as subcutaneous injection.

Question 10

What is the FDA approval status of Cinryze?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) approved Cinryze in October 2008. It was the first C1 esterase inhibitor approved in the United States for the routine prevention of hereditary angioedema (HAE) attacks.

Approved Indications

Cinryze is indicated for routine prophylaxis against angioedema attacks in the following populations:

Adults
Adolescents
Pediatric patients ages 6 years and older

The medication is intended for regular, scheduled use to prevent symptoms from occurring. It is not approved for the immediate treatment of an acute HAE attack.

Regulatory and Safety Oversight

As a biological product derived from human plasma, Cinryze is subject to strict regulatory standards regarding its manufacturing process. Because it is made from human blood, there is a theoretical risk of transmitting infectious agents, such as viruses or the agent that causes Creutzfeldt-Jakob disease. To mitigate these risks, the FDA requires rigorous donor screening and specific viral inactivation and removal steps during the manufacturing process.

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) programs required by the FDA for Cinryze.

Question 11

What should I know about Cinryze and cost?

Accepted Answer

Insurance and Prior Authorization

Cinryze is a specialty medication, which means it is often handled differently by insurance companies than standard prescriptions. Most insurance plans require prior authorization. During this process, a healthcare provider must submit documentation to the insurance company to confirm that the medication is medically necessary for the patient before coverage is approved.

Financial Assistance Programs

Because specialty medications can involve high out-of-pocket expenses, several resources may be available to help manage costs:

Copay Savings Cards: The manufacturer may offer programs for patients with commercial insurance to help reduce their monthly copayments.
Patient Assistance Programs: These programs are often available for individuals who are uninsured or underinsured and meet specific income criteria.
Non-profit Organizations: Some independent foundations provide grants to help patients with hereditary angioedema cover the costs of their treatments.

Factors Influencing Price

The total cost of treatment with Cinryze can be influenced by several factors, including:

The specific terms of an individual's health insurance policy, such as deductibles and coinsurance rates.
The dosage and frequency of administration prescribed by a doctor.
Whether the medication is dispensed through a specialty pharmacy or administered in a clinical setting.

Cinryze

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Cinryze

Hospitals.net Disclosure